Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: BLCO ) 20.63 -0.30 (-1.43%) Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about BLCO < Previous 1 2 3 Next > This Advance Auto Parts Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday October 15, 2024 Via Benzinga Why Bausch + Lomb Stock Soared by Over 7% on Monday October 14, 2024 It was quite a busy and eventful day for the company. Via The Motley Fool NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday October 14, 2024 Via Benzinga Topics Government Exposures Political Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces October 14, 2024 Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. Via Benzinga Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session October 02, 2024 Via Benzinga Why Bausch + Lomb Rallied Today September 16, 2024 The highly indebted healthcare stock rose on rumors it may be selling itself. Via The Motley Fool Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. Via Benzinga Topics Economy Exposures Interest Rates Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? September 22, 2024 Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. Via Benzinga Topics Economy Exposures Interest Rates Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday September 18, 2024 Via Benzinga Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues September 16, 2024 Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off. Via Benzinga Topics Supply Chain Exposures Supply Chain Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? September 16, 2024 Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns. Via Investor's Business Daily Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. Via Benzinga Topics Stocks Exposures US Equities Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know February 26, 2024 Via Benzinga Earnings Scheduled For February 21, 2024 February 21, 2024 Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. Via Benzinga Bausch & Lomb Earnings Preview February 20, 2024 Via Benzinga Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday September 16, 2024 Via Benzinga Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? July 31, 2024 Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting. Via Benzinga Topics Economy Exposures Interest Rates The Latest Analyst Ratings for Bausch & Lomb December 04, 2023 Via Benzinga Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility July 31, 2024 Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) Via Benzinga Topics Economy Exposures Interest Rates Why Is Clearside Biomedical Stock Gaining Today? June 25, 2024 Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS... Via Benzinga Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 24, 2024 Via Benzinga Do You Have Your Eye On Vision Care Stocks? May 20, 2024 For investors seeking stable and growing opportunities, eye care stocks are an attractive option. Via Talk Markets American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday May 06, 2024 Via Benzinga BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024 May 01, 2024 BLCO stock results show that Bausch & Lomb met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally May 01, 2024 A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD) Via Benzinga Topics Economy Exposures Interest Rates Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 21, 2024 Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly... Via Benzinga Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses February 21, 2024 Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders anticipates robust growth in 2024, projecting sales of $4.6-$4.7 billion and an... Via Benzinga Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday February 21, 2024 U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market February 21, 2024 The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think about the roadmap, an analyst said. Via Benzinga Topics Economy Exposures Interest Rates Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month February 09, 2024 "Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.